Eli Lilly Looks To Medical Records To Go After Compounders

BI
Buchanan Ingersoll & Rooney PC

Contributor

With 450 attorneys and government relations professionals across 15 offices, Buchanan Ingersoll & Rooney provides progressive legal, business, regulatory and government relations advice to protect, defend and advance our clients’ businesses. We service a wide range of clients, with deep experience in the finance, energy, healthcare and life sciences industries.
In an effort to gain more information regarding whether there is appropriate compounding to support weight loss drug products, Eli Lilly has decided to request medical records from users. This marks a new effort by Lilly...
United States Food, Drugs, Healthcare, Life Sciences

In an effort to gain more information regarding whether there is appropriate compounding to support weight loss drug products, Eli Lilly has decided to request medical records from users. This marks a new effort by Lilly in its continued efforts against compounded substitutes for its weight loss product that the company would assert are unlawful. As reported by Bloomberg, Lily wrote to users stating, "We recently learned that you took one of our products from a compounded pharmacy. . . We would appreciate if you could complete the enclosed form and sign the Authorization for Release of Medical Information so that we can obtain more details from the treating physician around your experience."

Eli Lilly & Co. is asking people who took copies of its blockbuster weight loss drug to give the company access to their medical records for safety reasons, a move that comes as it builds a case against businesses selling the compounded drugs.

news.bloomberglaw.com/...

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More